Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Olorofim effectively treats fungal skin infections.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Oral minipulse therapy with betamethasone effectively promotes hair regrowth in alopecia areata with fewer side effects.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Early diagnosis and treatment are crucial to prevent permanent hair loss from TNFα inhibitors in scalp psoriasis.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

PTHrP is important for bone formation and may be targeted for osteoporosis treatment and longevity therapies.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Topical IKKα inhibitors may help prevent CCS tumours.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Finasteride causes temporary cell death in BPH tissues.